India to begin trials for Ayurvedic drugs to fight COVID-19
The AYUSH Ministry is working to validate four Ayurvedic medicine formulations against COVID-19 along with Council of Scientific and Industrial Research (CSIR). The trials will begin within a week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients.
Union Minister of State for AYUSH Shripad Y Naik revealed this matter on Twitter. He hoped Ayurveda would show positive results to overcome this pandemic.
CSIR Director-General Shekhar Mande and AYUSH secretary Vaidya Rajesh Kotecha said that result will come within three months once the clinical trials begin.
CSIR Director-General Shekhar Mande said that Ayurveda principles existed long before and it is vital to validate at least some of them. It is the right time to validate Ayurvedic formulations to fight against coronavirus pandemic.
The AYUSH secretary said that four Ayurvedic formulations, Ashwagandha, Yashtimadhu (Mulethi), Guduchi and Pippali (Giloy) are going to be tested against COVID-19.
He added that repurposing of the malarial drug, AYUSH-64 will be done. He added that two stimulus studies are planned on the high-risk population for Ashwagandha. A competitive study has been planned between Hydroxychloroquine and Ashwagandha.
This clinical study will be conducted in various parts of the country with variable design. A task force has been formed to prepare guidelines for a clinical trial.
Many scientists across the country from the medical field from CSIR and other institutions have reviewed it. The advice of ICMR has also been taken in this regard.
They identified the centres and investigators and finalized all things for the clinical trial. AYUSH also approved to start the trial.
Standard drugs have been procured as per the standard size requirements. They are planning to begin the trials in the next week.
Image Credit: Image by Pradeep Kumar from Pixabay (Free for commercial use)
You may also like
Image Reference: https://pixabay.com/photos/ayurvedic-herbal-alternative-756352/
Recent Posts
- Deendayal Port Authority opens Assistant Manager RecruitmentThe Deendayal Port Authority Recruitment 2025 notification invites applications for 10 Assistant Manager posts.
- Census 2027 sets stage for historic digital and caste enumerationThe Union government has formally notified Phase I of Census 2027, beginning with houselisting operations.
- Lucknow Metro Phase 1B moves ahead with elevated stationsLucknow’s metro expansion has taken a key step forward as work on the second corridor gathers momentum. The Uttar Pradesh Metro Rail Corporation has floated a ₹492.22 crore tender to build five elevated stations under Phase 1B.
- Deendayal Port Authority opens Assistant Manager Recruitment
What’s new at WeRIndia.com
News from 700+ sources
-
BHEL shares up after sharp fall, brokerages assess reports of easing curbs on Chinese firms
-
Benchmark indices trade lower on foreign fund outflows, renewed concerns over tariff hikes
-
`Because of my appearance, I don`t get films like Ikkis`: Vivaan Shah
-
BHEL shares rally 5% after hitting lower circuit on China concerns. Should you buy, sell or hold?
-
Markets brace for Supreme Court verdict on Trumps emergency tariffs
-
Tara Sutaria, Veer Pahariya breakup: From viral PDA moments to AP Dhillion concert controversy, know the timeline
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..








Leave a Reply